Clinical Trials Directory

Trials / Completed

CompletedNCT01668849

Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer

Preliminary Clinical Trial Investigating the Ability of Plant Exosomes to Abrogate Oral Mucositis Induced by Combined Chemotherapy and Radiation in Head and Neck Cancer Patients

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
60 (actual)
Sponsor
University of Louisville · Academic / Other
Sex
All
Age
20 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate the ability of grape exosomes, given to the subject as grape powder, as an important anti-inflammatory agent to reduce the incidence of oral mucositis during radiation and chemotherapy treatment for head and neck tumors.

Detailed description

The purpose of this study is to investigate the ability of plant (grape) exosomes to prevent oral mucositis associated with chemoradiation treatment of head and neck cancer. Also, to be evaluated is the effect of grape exosomes on the production of cytokines and immune responses to tumor exosomal antigens, metabolic and molecular markers in these patients.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGrape extractGrape extract self-administered by mouth daily for 35 days
DRUGLortab, Fentanyl patch, mouthwashLortab 5-10 mg Fentanyl patch 25 mcgs Mary's Magic Mouthwash

Timeline

Start date
2012-08-02
Primary completion
2022-05-25
Completion
2022-06-03
First posted
2012-08-20
Last updated
2022-08-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01668849. Inclusion in this directory is not an endorsement.